arrow
U

Ulf Schönermarck

University Hospital, LMU Munich
H指数:27
被引数:3,755

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Rituximab limits glucocorticoid use in IgG4-related disease: Real-world evidence from a large European cohort

利妥昔单抗可限制IgG4相关疾病中的糖皮质激素使用:来自大型欧洲队列的真实世界证据

2026-03-190
PRE
Characteristics and Management of Patients With Immune Thrombotic Thrombocytopenic Purpura Admitted to the Intensive Care Unit: A Multicenter Retrospective Analysis

免疫性血栓性血小板减少性紫癜入住重症监护室患者的特征与管理:一项多中心回顾性分析

2025-10-290
OAAI
Effectiveness and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients

利妥昔单抗在IgG4相关疾病四种表型中的有效性与安全性:一项欧洲多中心队列研究,涉及115例患者

2025-08-190
PRE
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
2023-03-0124
OAAI
Diminished Short- and Long-Term Antibody Response after SARS-CoV-2 Vaccination in Hemodialysis Patients

血液透析患者SARS-CoV-2疫苗接种后短期和长期抗体反应减弱

2022-04-137
OAAI
Polyomavirus exerts detrimental effects on renal function in patients after lung transplantation
2021-12-014
PREAI
ANCA Vasculitis Induction Management During the COVID-19 Pandemic
2021-11-019
OAAI